Active Ingredient(s): Levobupivacaine
FDA Approved: * August 5, 1999
Pharm Company: * PURDUE PHARMA LP
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Chirocaine Overview

Levobupivacaine (rINN) /livobjupvken/ is a local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine.[1] Levobupivacaine hydrochloride is commonly marketed by AbbVie under the trade name Chirocaine.[2] Contents 1 Clinical use 1.1 Indications 1.2 Contraindications 1.3 Adverse effects 1.4 Postarthroscopic glenohumeral chondrolysis 2 References Clinical use Compared to bupivacaine, levobupivacaine is associated with...

Read more Chirocaine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Chirocaine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 2.5mg/ml, 5mg/ml, 7.5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Levobupivacaine or a similar ingredient: (1 result)